MITA's new set of management standards for CT equipment aims to help manufacturers comply with dose mitigation and reporting features.
A new set of management standards for CT equipment aims to help manufacturers comply with dose mitigation and reporting features.
The Medical Imaging and Technology Alliance (MITA)’s Smart Dose - formally known as XR-29 Standard Attributes on Computer Tomography (CT) Equipment Related to Dose Optimization and Management - was announced last month and combines four features of CT equipment that help optimize the management of radiation dose: DICOM Dose Structured Reporting, pediatric and adult reference protocols, CT Dose Check, and Automatic Exposure Controls.
“There are no new features in XR-29, but rather the idea was to pull dose mitigation and dose reporting features into one standard that manufacturers can note on their equipment as being compliant with,” Gail Rodriguez, executive director of MITA, said in an interview. “This was done with the hope that if you put those separate features into a standard it can help to drive adoption and utilization among healthcare and imaging providers.”
MITA’s announcement was backed by comments from both the Deputy Director for Radiological Health at the FDA and other industry leaders
“Above all, the medical imaging team that includes the manufacturers of imaging equipment are committed to putting the patient’s safety, health and welfare first,” Marilyn Goske, MD, of Cincinnati Children’s and Chair of the Image Gently campaign, said in a release. “The approval of this new CT standard represents another important step forward in ensuring patients, particularly children, have access to the safest, most advanced technology available.”
Equipment that meets the new Smart Dose standards will include:
“This is a result of all of the imaging community working together,” Rodriguez said. “There is a galvanized effort to include new features on imaging scanners to reduce dose without sacrificing image quality.”
Since the new standards were announced, both Toshiba and Siemens have announced measures to comply with the new standards. Toshiba announced that all of its new Aquilion CT systems will meet the standards, and Siemens Healthcare announced that all of its new Somatom CT products will as well.
“It is our collective hope,” Rodriquez said, “that this will drive compliance, and help providers to say that they are doing everything that they can to make sure that patient safety is guarded.”
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.